Latest Advances in Molecular Pathology
About the DVD:
This course is designed to educate practicing pathologists on the current molecular diagnostics technologies. This three part course is produced in collaboration between Cambridge Healthtech Institute and the College of American Pathologists.
About the Conference:
Molecular Med Tri-Con is a five day event where over 3,000 attendees participate in interactive lectures, discussions, various receptions which offer numerous networking and learning opportunities. The Tri-Conference is the leading scientific event to hear differing views and perspectives on poignant issues facing you and our industry today.
About the DVD:
Over 130 Minutes
Site License: $1380
Agenda At A Glance:
Introduction to Molecular Pathology Methods
Iris Schrijver, M.D., FCAP, Associate Professor of Pathology and Pediatrics, Director, Molecular Pathology Laboratory, Stanford University Medical Center, Lucile Packard Children's Hospital
The presentation is focused on the basic principles of genetics and genetic testing, as directly applicable to molecular genetic pathology practice. Examples of molecular testing methods will be covered in an interactive way and placed in the context of disease examples. Advantages and limitations will be explained for each method.
Biography: Iris Schrijver, M.D. received her medical degree from the University of Utrecht in The Netherlands and completed a post-doctoral research fellowship at Stanford University. She is a diplomate of the American Board of Medical Genetics, and holds specialty certification in Clinical Molecular Genetics. In addition, she trained in Clinical Pathology at Stanford University and is a diplomate of the American Board of Pathology. Dr. Schrijver currently is Associate Professor of Pathology and (by courtesy) Pediatrics. She directs the diagnostic Molecular Pathology laboratory as well as the Molecular Genetic Pathology fellowship program and is Associate Program Director for residency training in Clinical Pathology. Her research interests include cystic fibrosis and hereditary hearing loss.
Molecular Diagnostic Cancer Testing
Michael H. A. Roehrl, M.D., Ph.D.Assistant Professor of Pathology and Laboratory Medicine, Boston Medical Center Scientific Director, BioBank at Boston Medical Center Medical Director, Laboratory Outreach Operations
The understanding of molecular aberrations in malignancies continues to revolutionize diagnosis and treatment of these diseases. This introductory lecture will focus on a variety of genomic, transcriptomic, and protein-based tests and their use in selected human cancers.
Cytogenetic Testing and Microarray Comparative Genomic Hybridization
Athena Cherry, Ph.D., Director, Cytogenetics Laboratory, Professor, Pathology and Pediatrics, Stanford Comprehensive Cancer Center
Cytogenetic testing includes chromosomal analysis, fluorescence in situ hybridization (or FISH) and array comparative genomic hybridization (or aCGH). Chromosomal analysis and FISH are routinely used in a wide variety of clinical/diagnostic situations. Currently, aCGH is routinely used as a first line test in children with multiple congenital anomalies. The clinical utility of aCGH in the diagnosis/prognosis and treatment strategies in leukemias, lymphomas and other malignancies is being investigated.